| Announce Date | 10/29/2025 |
| EPS Normalized Actual | $1.22 (Beat by $0.05) |
| EPS GAAP Actual | $1.22 (Beat by $0.05) |
| Revenue Actual | $2.20043B |
| Revenue Surprise | Beat by $2200.43M |
| Announce Date | 12/31/1969 (Pre-Market) |
| EPS Normalized Estimate | $ |
| EPS GAAP Estimate | $ |
| Revenue Estimate | $0B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 8.95 | 7.33 | 8.77987 | 9.07591 | 4 |
| Dec 2029 | 7.93 | 8.27 | 7.76411 | 8.02703 | 2 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.23 | 1.23 | 2.20043B | 11.57% | 2200.43M |
| FQ2 2025 (Jun 2025) | 1.35 | 1.35 | 2.2206B | 14.73% | 2220.6M |
| FQ1 2025 (Mar 2025) | 1.81 | 1.81 | 2.23644B | 15.77% | 2236.44M |
| FQ4 2024 (Dec 2024) | 0.8 | 0.8 | 1.99623B | 14.91% | 1996.23M |
| FQ3 2024 (Sep 2024) | 0.91 | 0.91 | 1.94574B | 13.03% | 1945.74M |
| FQ2 2024 (Jun 2024) | 0.95 | 0.95 | 1.89352B | 100% | 1893.52M |
| FQ1 2024 (Mar 2024) | 1.13 | 1.13 | 1.88381B | 16.31% | 1883.81M |
| FQ4 2023 (Dec 2023) | 0.49 | 0.49 | 1.69855B | 100% | 1698.55M |
FQ4 Announce Date
12/31/1969 (Pre-Market)
Consensus EPS Estimates
Consensus Revenue Estimates
0B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.2033 | -- | 1.18394 | 1.23066 | 3 |
| FQ3 2027 (Sep 2027) | 1.3405 | -- | 1.32487 | 1.35263 | 3 |
| FQ2 2027 (Jun 2027) | 1.4376 | -- | 1.42084 | 1.45061 | 3 |
| FQ1 2027 (Mar 2027) | 1.9236 | -- | 1.90117 | 1.94101 | 3 |
| FQ4 2026 (Oct 2026) | 0.8018 | -- | 0.78858 | 0.81762 | 4 |
| FQ3 2026 (Sep 2026) | 1.09323 | -12.51 | 1.06025 | 1.11359 | 3 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 2.65B | -- | 2.62B | 2.7B | 5 |
| FQ3 2027 (Sep 2027) | 2.61B | -- | 2.59B | 2.63B | 4 |
| FQ2 2027 (Jun 2027) | 2.61B | -- | 2.59B | 2.63B | 4 |
| FQ1 2027 (Mar 2027) | 2.66B | -- | 2.64B | 2.68B | 4 |
| FQ4 2026 (Oct 2026) | 2.14B | -- | 2.11B | 2.17B | 4 |
| FQ3 2026 (Sep 2026) | 2.34B | 5.84 | 2.28B | 2.37B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
8
EPS # of Misses
0
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.23 | 1.23 | 100% | |
| FQ2 2025 (Jun 2025) | 1.35 | 1.35 | 100% | |
| FQ1 2025 (Mar 2025) | 1.81 | 1.81 | 100% | |
| FQ4 2024 (Dec 2024) | 0.8 | 0.8 | 100% | |
| FQ3 2024 (Sep 2024) | 0.91 | 0.91 | 100% | |
| FQ2 2024 (Jun 2024) | 0.95 | 0.95 | 100% | |
| FQ1 2024 (Mar 2024) | 1.13 | 1.13 | 100% | |
| FQ4 2023 (Dec 2023) | 0.49 | 0.49 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0B | $2.2B | $2200.43M | 100% |
| FQ2 2025 (Jun 2025) | $0B | $2.22B | $2220.6M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $2.24B | $2236.44M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $2B | $1996.23M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $1.95B | $1945.74M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $1.89B | $1893.52M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $1.88B | $1883.81M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $1.7B | $1698.55M | 100% |